Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$34.10

1.47 (4.51%)

11:14
02/07/18
02/07
11:14
02/07/18
11:14

Pompe could have 'major impact' on Audentes valuation, says H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay noted that the incidence of Pompe disease is materially higher than the diseases targeted by Audentes Therapeutics' existing clinical programs, which means the AT982 drug product is likely to have a major impact on valuation if it shows compelling clinical activity. After the company announced its selection of a clinical development candidate for its Pompe program and shared timeline expectations, Chattopadhyay reiterated his Buy rating and $37 price target on the stock.

BOLD Audentes Therapeutics
$34.10

1.47 (4.51%)

12/20/17
HCWC
12/20/17
INITIATION
Target $37
HCWC
Buy
Audentes Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay started Audentes Therapeutics with a Buy rating and $37 price target. The analyst views the company's market positioning in AAV-based gene therapy as compelling and believes 2018 is "catalyst-filled."
01/04/18
PIPR
01/04/18
NO CHANGE
Target $45
PIPR
Overweight
Piper ups Audentes target to $45 on 'far' better than expected data
Piper Jaffray analyst Christopher Raymond raised his price target for Audentes Therapeutics to $45 from $36 saying the initial data for AT132 in X-Linked Myotubular Myopathy is "far" better than expected." The stock in morning trading is up 13% to $40.08. While elevated troponin levels seen in one patient is noteworthy, mitigating circumstances, combined with "truly remarkable efficacy," more than offsets this concern, Raymond tells investors in a research note. The analyst believes six month data next quarter is likely to solidify AT132's therapeutic premise. He remains a buyer of Audentes shares with an Overweight rating.
01/04/18
WEDB
01/04/18
NO CHANGE
Target $56
WEDB
Outperform
Audentes price target raised to $56 from $29 at Wedbush
Wedbush analyst David Nierengarten raised his price target for Audentes Therapeutics to $56 saying the first dose cohort data from the Phase 1/2 trial for AT132 in X-Linked Myotubular Myopathy is "impressive." Treated patients experienced "significant and rapid improvements in several important functional metrics," Nierengarten tells investors in a research note. The analyst expects additional confirmatory updates throughout the year and keeps an Outperform on Audentes shares.
01/05/18
BMOC
01/05/18
NO CHANGE
Target $44
BMOC
Outperform
Audentes Therapeutics price target raised to $44 from $35 at BMO Capital
BMO Capital analyst Matthew Luchini raised his price target on Audentes Therapeutics to $44 after the company's release of initial AT132 Phase I/II data for the treatment of X-Linked Myotubular Myopathy. The analyst says the results offer a "proof of concept", adding he is encouraged by the improvements in neuromuscular and respiratory function from the treatment. Luchini keeps his Outperform rating on Audentes Therapeutics.

TODAY'S FREE FLY STORIES

BX

Blackstone

$32.72

-0.31 (-0.94%)

, GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

17:56
06/19/18
06/19
17:56
06/19/18
17:56
Hot Stocks
Blackstone to acquire PSAV »

PSAV announced that it…

BX

Blackstone

$32.72

-0.31 (-0.94%)

GS

Goldman Sachs

$228.20

-3.185 (-1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:42
06/19/18
06/19
17:42
06/19/18
17:42
Recommendations
Starbucks analyst commentary  »

Starbucks has no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:36
06/19/18
06/19
17:36
06/19/18
17:36
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle reverses, now down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Earnings
Oracle sees Q1 adjusted EPS 67c-69c in USD, consensus 72c »

Sees Q1 adjusted EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Hot Stocks
Walgreens Boots Alliance to replace General Electric in DJIA »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BA

Boeing

$341.10

-13.69 (-3.86%)

, FDX

FedEx

$258.35

-5.295 (-2.01%)

17:32
06/19/18
06/19
17:32
06/19/18
17:32
Hot Stocks
Boeing announces FedEx order valued at $6.6B for 24 medium and large freighters »

Boeing (BA) and FedEx…

BA

Boeing

$341.10

-13.69 (-3.86%)

FDX

FedEx

$258.35

-5.295 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Sep

  • 21

    Sep

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

17:31
06/19/18
06/19
17:31
06/19/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Walgreens Boots Alliance »

Walgreens jumps 4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:29
06/19/18
06/19
17:29
06/19/18
17:29
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Catz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

GE

General Electric

$12.96

-0.24 (-1.82%)

17:26
06/19/18
06/19
17:26
06/19/18
17:26
Hot Stocks
Breaking Hot Stocks news story on General Electric »

GE drops 21c to $12.74…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPOP

Popular

$46.64

0.19 (0.41%)

17:26
06/19/18
06/19
17:26
06/19/18
17:26
Syndicate
Breaking Syndicate news story on Popular »

Popular files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRAX

Social Reality

$4.66

0.2 (4.48%)

17:25
06/19/18
06/19
17:25
06/19/18
17:25
Syndicate
Breaking Syndicate news story on Social Reality »

Social Reality files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:25
06/19/18
06/19
17:25
06/19/18
17:25
Conference/Events
Stephens restaurants analyst to hold a dinner meeting »

Restaurant Analyst…

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says June comp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Earnings
Breaking Earnings news story on Oracle »

Oracle sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

VALE

Vale

$12.97

-0.21 (-1.59%)

17:23
06/19/18
06/19
17:23
06/19/18
17:23
Syndicate
Breaking Syndicate news story on Vale »

Vale files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

, GE

General Electric

$12.96

-0.24 (-1.82%)

17:21
06/19/18
06/19
17:21
06/19/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Walgreens Boots Alliance, General Electric »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$64.61

0.47 (0.73%)

GE

General Electric

$12.96

-0.24 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

RMTI

Rockwell Medical

$5.47

0.07 (1.30%)

17:20
06/19/18
06/19
17:20
06/19/18
17:20
Hot Stocks
Rockwell Medical parties to engage in mediation June 19 »

On June 13, the Circuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:18
06/19/18
06/19
17:18
06/19/18
17:18
Hot Stocks
Oracle sees FY19 CapEx 'similar' to FY18 »

Sees FY19 tax rate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:16
06/19/18
06/19
17:16
06/19/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees some EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:16
06/19/18
06/19
17:16
06/19/18
17:16
Earnings
Starbucks cuts FY18 adjusted EPS view to $2.39-$2.43 from $2.48-$2.53 

Consensus $2.49.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

VALE

Vale

$12.97

-0.21 (-1.59%)

17:15
06/19/18
06/19
17:15
06/19/18
17:15
Hot Stocks
Vale exposed to about 40% of future cobalt production from Voisey's Bay »

On June 11 , Vale…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$57.43

0.22 (0.38%)

17:14
06/19/18
06/19
17:14
06/19/18
17:14
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says May 29…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 22

    Jun

FDX

FedEx

$258.35

-5.295 (-2.01%)

17:13
06/19/18
06/19
17:13
06/19/18
17:13
Hot Stocks
FedEx sees new pension accounting rules reducing operating margins by 90bps »

Expects much lower…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Sep

  • 21

    Sep

CCNI

Command Center, Inc

$5.45

-0.1 (-1.80%)

17:11
06/19/18
06/19
17:11
06/19/18
17:11
Hot Stocks
Breaking Hot Stocks news story on Command Center, Inc »

Ephraim G. Fields reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$46.29

-0.25 (-0.54%)

17:09
06/19/18
06/19
17:09
06/19/18
17:09
Hot Stocks
Breaking Hot Stocks news story on Oracle »

Oracle CEO Catz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.